Scientech Research’s Curanex Pharmaceuticals CURX Stock Holding History
Bought
Maintained
Sold
Other funds holding CURX
Scientech Research's CURX Position: Q4 2025 in Review
Scientech Research sold out of Curanex Pharmaceuticals (CURX) in Q4 2025, closing a stake of 724 shares — an estimated $10.4K sold.
Scientech Research first reported a position in CURX in Q3 2025 and held it in 1 quarter. The position peaked at $10.4K in Q3 2025. 11 funds tracked by Wall St. Rank hold CURX as of Q4 2025.
- Scientech Research reported no remaining Curanex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Scientech Research sold 724 Curanex Pharmaceuticals shares in Q4 2025, an estimated $10.4K.
- Scientech Research first reported a position in Curanex Pharmaceuticals in Q3 2025 and held it in 1 quarter.
- Scientech Research's Curanex Pharmaceuticals position peaked at $10.4K in Q3 2025.
- 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q4 2025.
Based on Scientech Research's 13F filing for Q4 2025, filed 17 Feb 2026.